Centessa Pharmaceuticals's total assets for Q3 2025 were $448.30M, a decrease of -8.91% from the previous quarter. CNTA total liabilities were $146.73M for the fiscal quarter, a -0.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.